Cognitive Trials

Active Studies

  • A Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of MK-8931 with a Long Term Double-Blind Extension in Subjects with Mild to Moderate Alzheimer’s Disease.
  • A comparison of  the efficacy of Behavioral Activation (BA) and Supportive Therapy (ST) to prevent cognitive decline in older African Americans with Mild Cognitive Impairment (MCI)
  • Improving Medication Adherence in Older African Americans with Diabetes
  • Collaborative Care for Depression and Diabetic Retinopathy in African Americans